Jefferies, Cardinal Health
The website you are visiting is protected and accelerated by Incapsula. Your computer may have been infected by malware and ...
Cardinal Health (NYSE:CAH) reported its second-quarter earnings for fiscal year 2024, surpassing analyst expectations with an ...
Cardinal Health (NYSE:CAH – Get Free Report) had its price target upped by equities researchers at Wells Fargo & Company from ...
Argus analyst Kristina Ruggeri raised the firm’s price target on Cardinal Health (CAH) to $148 from $145 and keeps a Buy rating on the shares.
Jan 30 (Reuters) - Drug distributor Cardinal Health on Thursday raised its fiscal 2025 adjusted profit forecast as strong ...
Cardinal Health reported an increase in revenue for two of its segments, while the departure of Optimum impacted its ...
Draped in Mexican and Salvadoran flags, roughly 1,000 demonstrators gathered near City Hall shortly before noon, blocking ...
Cardinal Health Inc. closed 5.65% below its 52-week high of $132.84, which the company achieved on January 30th.
Latest data shows the largest indicative borrow rate increases among liquid option names include: Sellas Life Sciences (SLS) 69.57% +2.56, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback